Commonwealth Biotechnologies, Inc.
911 East Leigh Street
Suite G-19
Richmond
Virginia
21219
United States
Tel: 804-648-3820
Fax: 804-648-2641
85 articles about Commonwealth Biotechnologies, Inc.
-
HedgePath Pharmaceuticals Completes Reorganization Plan With Commonwealth Biotechnologies, Inc.
8/19/2013
-
Commonwealth Biotechnologies, Inc. Says It has Emerged From Chapter 11
4/18/2013
-
Commonwealth Biotechnologies, Inc. 2011 Annual Shareholder Vote & Meeting Update Information
3/30/2011
-
Commonwealth Biotechnologies, Inc. 2011 Annual Shareholder Vote & Meeting Update Information
3/30/2011
-
Commonwealth Biotechnologies, Inc. Repudiates SEC Filings by William Guo
3/16/2011
-
Commonwealth Biotechnologies, Inc. Announces Signing of Share Purchase Agreement to Sell Mimotopes Pty. Ltd. to Leadtec Systems Australia Pty Ltd.
10/28/2010
-
Commonwealth Biotechnologies, Inc. Provides Market Update
7/28/2010
-
Commonwealth Biotechnologies, Inc. Announces Appointment of Richard J. Freer, Ph.D. as Chief Executive Officer
7/27/2010
-
The Commonwealth Biotechnologies, Inc.-GL Biochem (Shanghai) Ltd Acquisition: Market Update and Transaction Progress
3/26/2010
-
Commonwealth Biotechnologies, Inc. Announces Move to the OTC Bulletin Board
3/25/2010
-
Commonwealth Biotechnologies, Inc. Announces Signing of Definitive Share Purchase Agreement to Acquire GL Biochem (Shanghai) Ltd
1/4/2010
-
Commonwealth Biotechnologies, Inc. Completes Divestment of Bioanalytical and Genetic Testing Business Assets
11/10/2009
-
Commonwealth Biotechnologies, Inc. Receives NASDAQ Notice
10/23/2009
-
Commonwealth Biotechnologies, Inc.. Acquisition of GL Biochem (Shanghai) Ltd: Market Update
10/14/2009
-
Commonwealth Biotechnologies, Inc. Receives NASDAQ Notification Regarding Bid Price; Grace Period Granted Through March 15, 2010
9/21/2009
-
Commonwealth Biotechnologies, Inc., Seeking to Acquire Shanghai's GL Biochem (Shanghai) Ltd, Faces Delisting
8/4/2009
-
Commonwealth Biotechnologies, Inc. Provides Market Update
8/3/2009
-
Commonwealth Biotechnologies, Inc. Announces Completion of Stock Issuance and Receipt of Intellectual Property
7/23/2009
-
Commonwealth Biotechnologies, Inc. Enters Into Agreement With Bostwick Laboratories to Sell the Assets of its CBI Services and Fairfax Identity Laboratories Divisions
7/21/2009
-
Commonwealth Biotechnologies, Inc. Reaches Agreement on Extending Convertible Notes
7/10/2009